Trials / Completed
CompletedNCT00000449
Behavior and Naltrexone Treatment for Alcoholics
Coping, Exposure, and Naltrexone Treatment With Alcoholics
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study's purpose is to improve alcoholism treatment by investigating the combined effectiveness of a psychotherapy (Coping Skills Training and Cue Exposure Treatment - CSTCET) with naltrexone in a randomized clinical trial. Individuals will receive 2 weeks of CSTCET or a control treatment as inpatients followed by 12 consecutive weeks of receiving either naltrexone or placebo as outpatients. Followups at 24, 48, and 72 weeks after treatment is completed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | naltrexone (Revia) | |
| BEHAVIORAL | cognitive behavioral therapy | |
| BEHAVIORAL | cue exposure treatment |
Timeline
- Completion
- 2000-03-01
- First posted
- 1999-11-03
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000449. Inclusion in this directory is not an endorsement.